| Ytd | -7.73% | |
| 1y | 4.36% |
| Open | 166.98 | Prev Close | 167.62 | Low | 166.19 | High | 168.82 | Mkt Cap | 12.72B |
| Vol | 510.79K | Avg Vol | 904.33K | EPS | 9.14 | P/E | 18.36 | Forward P/E | 15.00 |
| Beta | 0.80 | Short Ratio | 2.02 | Inst. Own | 100.27% | Dividend | 4.00 | Div Yield | 2.39 |
| Ex Div Date | 09-02 | Earning | 10-29 | 50-d Avg | 174.08 | 200-d Avg | 172.48 | 1yr Est | 199.60 |
AVY News
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t
On CNBC's “Mad Money Lightning Round,” Jim Cramer said Sarepta Therapeutics, Inc. (NASDAQ:SRPT) is a
Cramer called Sarepta controversial, praised Avery Dennison and Ciena, favored ING and Santander, an
UBS analyst Joshua Spector maintains Avery Dennison (NYSE:AVY) with a Buy and raises the price ta
Citigroup analyst Anthony Pettinari maintains Avery Dennison (NYSE:AVY) with a Neutral and raises
JP Morgan analyst Jeffrey Zekauskas maintains Avery Dennison (NYSE:AVY) with a Overweight and rai
Avery Dennison (NYSE:AVY) reported quarterly earnings of $2.89 per share which beat the analyst cons
Truist Securities analyst Michael Roxland maintains Avery Dennison (NYSE:AVY) with a Buy and lowe
B of A Securities analyst George Staphos maintains Avery Dennison (NYSE:AVY) with a Buy and raise
Citigroup analyst Anthony Pettinari maintains Avery Dennison (NYSE:AVY) with a Neutral and lowers
Citigroup analyst Anthony Pettinari maintains Avery Dennison (NYSE:AVY) with a Neutral and lowers
JP Morgan analyst Jeffrey Zekauskas maintains Avery Dennison (NYSE:AVY) with a Overweight and low
Truist Securities analyst Michael Roxland reiterates Avery Dennison (NYSE:AVY) with a Buy and low
Avery Dennison (NYSE:AVY) reported quarterly earnings of $2.47 per share which beat the analyst cons
Expanding Joint Go-to-Market Efforts, Preferred Inlay Design and Manufacturing Partnership to Accele
This strategic investment deepens the long-standing partnership dedicated to creating a more intell
Truist Securities analyst Michael Roxland maintains Avery Dennison (NYSE:AVY) with a Buy and lowe
Citigroup analyst Anthony Pettinari maintains Avery Dennison (NYSE:AVY) with a Neutral and lowers
UBS analyst Joshua Spector maintains Avery Dennison (NYSE:AVY) with a Buy and lowers the price ta
Deutsche Bank analyst Hillary Cacanando initiates coverage on Avery Dennison (NYSE:AVY) with a Bu
JP Morgan analyst Jeffrey Zekauskas maintains Avery Dennison (NYSE:AVY) with a Overweight and rai
Citigroup analyst Anthony Pettinari maintains Avery Dennison (NYSE:AVY) with a Neutral and raises
BMO Capital analyst John McNulty maintains Avery Dennison (NYSE:AVY) with a Outperform and raises
UBS analyst Joshua Spector maintains Avery Dennison (NYSE:AVY) with a Buy and raises the price ta
Avery Dennison Corporation (NYSE: AVY) stock rose on Wednesday after posting Q4 fiscal 2025 results,
Avery Dennison (NYSE:AVY) reported quarterly earnings of $2.45 per share which beat the analyst cons
It was a quiet Tuesday on Wall Street, as major indexes edged lower with investors pausing ahead of
Companies Reporting Before The Bell • Novartis (NYSE:NVS) is likely to report quarterly earnings at
Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is estimated to report quarterly earn
Companies Reporting Before The Bell • Unilever (NYSE:UL) is expected to report earnings for its fir
Companies Reporting Before The Bell • Teck Resources (NYSE:TECK) is expected to report quarterly ea